Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00969943 · ClinicalTrials.gov registry record

Gender Differences in Response to Cues in Cocaine Dependence

A clinical trial of Cocaine Dependence, sponsored by Medical University of South Carolina.

Completed
Registry status
1
Study location

NCT00969943 is a study of Cocaine Dependence that has completed, run by Medical University of South Carolina. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00969943, a study of Cocaine Dependence, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
1
Study location

Study Summary

The purpose of this study is to evaluate whether men and women respond differently to seeing items related to cocaine use or to remembering stressful events. Four groups of individuals will be recruited to participate in this study: men with cocaine dependence, women with cocaine dependence, men without cocaine dependence, and women without cocaine dependence. Hypothesis #1: Cocaine-dependent women will demonstrate smaller increases in neuroendocrine, but greater increases in heart rate and more cocaine craving and subjective distress when exposed to stress as compared to cocaine-dependent men and non cocaine-dependent men and women. Hypothesis #2: Cocaine-dependent men will demonstrate greater increases in neuroendocrine, but greater increases in heart rate and more cocaine craving and subjective distress when exposed to cocaine-related cues as compared to cocaine-dependent women and non cocaine-dependent men and women. Hypothesis #3: Cocaine-dependent women will demonstrate greater increases in heart rate and more cocaine craving and subjective distress when exposed to stress inducing stimuli as compared to their own responses to a cocaine-related cue. Hypothesis #4: The neuroendocrine response to a stress hormone (corticotropin releasing hormone; CRH) will be greater in cocaine-dependent women as compared to cocaine-dependent men.

Conditions Studied

Study Locations (1)

South Carolina

  • MUSC-Clinical Neurosciences Division - Charleston

Trial Details

FieldValue
Start Date 2003-03
Est. Completion 2007-08

What the Registry Record Tells You About NCT00969943

The ClinicalTrials.gov registry entry for NCT00969943 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 0 interventions.

NCT00969943 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT00969943 about?

NCT00969943 is a clinical study titled "Gender Differences in Response to Cues in Cocaine Dependence". The purpose of this study is to evaluate whether men and women respond differently to seeing items related to cocaine use or to remembering stressful events. Four groups of individuals will be recruited to participate in this study: men with cocaine dependence, women with cocaine dependence, men wit...

What is the current status of trial NCT00969943?

This trial is currently completed. The study started on 2003-03. Estimated completion is 2007-08.

What conditions does trial NCT00969943 study?

This clinical trial studies the following conditions: Cocaine Dependence.

Who is sponsoring clinical trial NCT00969943?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00969943 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.